Viewing Study NCT04624906


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2026-03-01 @ 3:41 AM
Study NCT ID: NCT04624906
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-17
First Post: 2020-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
Sponsor: Sunnybrook Health Sciences Centre
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module